David Grew 🛠🏥

Radiation Oncologist. I help clinical trial sponsors convert protocols into scalable video assets • Building leverage around patient education at @primr_med

[David Grew 🛠🏥 @DoctorGrew]

We are going to make it normal for people with a new diagnosis of cancer to understand their disease and the appropriate treatment before they even meet their oncologist.

[David Grew 🛠🏥 @DoctorGrew]

🎉 Congrats to @NRGonc & PIs @ndesai2005 and @aleberlin2 on hitting accrual target for NRG-GU010 (GUIDANCE)!

Thank you both for partnering with us to create the 3-part video series—trusting PRIMR to produce patient-centric educational content.

#ProstateCancer #ClinicalTrials

[David Grew 🛠🏥 @DoctorGrew]

PRIMR provides the clarity sponsors need to enhance patient and site engagement throughout clinical trials. 💡🏥

https://t.co/Y8MfSTYZFL

#cancer #clinicaltrials #clinicalresearch #patienteducation #prostatecancer

[David Grew 🛠🏥 @DoctorGrew]

#PRIMR turns trials into engaging visual stories.

The RadiCaL Study is testing whether adding Radium-223 to treatment can target kidney cancer that has spread to bones and reduce pain.

Watch:
https://t.co/krupl6tIiX

@DrRanaMcKay @ALLIANCE_org

[David Grew 🛠🏥 @DoctorGrew]

New blog! 📢

Ever wonder how to target cancer precisely and spare healthy tissue when chemo fails?

In this blog, we discover what antibody-drug conjugates (ADCs) are, how they work, and why they're a game-changer in precision oncology.

https://t.co/57DTdeRnJ6

[David Grew 🛠🏥 @DoctorGrew]

Boost trial enrollment with PRIMR’s clear video resources.

Empower patients with simple, trusted info for confident participation. 📊💡

https://t.co/Y8MfSTYZFL

#cancer #clinicaltrials #clinicalresearch #patienteducation #lungcancer

[David Grew 🛠🏥 @DoctorGrew]

Nobody particularly wants to have a colonoscopy, mostly because the prep is unpleasant and the general idea of the procedure is rather unappealing.

In this video, we tackle 3 main reasons to get a colonoscopy:

▪ Screening
▪ Diagnosis
▪ Surveillance

https://t.co/KWIHBJR8pd

[David Grew 🛠🏥 @DoctorGrew]

PRIMR’s insights help sponsors pinpoint the best strategies for engaging patients and sites in clinical trials. 🎯🔍

https://t.co/Y8MfSTYrQd

#cancer #clinicaltrials #clinicalresearch #patienteducation #prostatecancer

[David Grew 🛠🏥 @DoctorGrew]

#PRIMR connects patients and doctors via clear videos.

The RTIRE trial tests whether electric pulse therapy (IRE) plus low-dose radiation can effectively control prostate cancer with fewer side effects.

Watch:
https://t.co/kLUbQlkxz9

@TimMcClureMD @WeillCornell

[David Grew 🛠🏥 @DoctorGrew]

In this blog, we explore how EGFR-positive lung cancer forms, why testing matters, and its game-changing role in personalized care.

Read the full blog:
https://t.co/gJxEVcUAgr

[David Grew 🛠🏥 @DoctorGrew]

New blog! 📢

Why do similar lung cancers get different treatments?

It boils down to genetic drivers like EGFR mutations.

@jillfeldman4 @EGFRResisters @FawziAbuRous @lungoncdoc @ADesaiMD

[David Grew 🛠🏥 @DoctorGrew]

Make clinical trials accessible to all with PRIMR’s educational video solutions.

Improving clarity and understanding every step. 🎬🔍

https://t.co/Y8MfSTYZFL

#cancer #clinicaltrials #clinicalresearch #patienteducation #prostatecancer

[David Grew 🛠🏥 @DoctorGrew]

New video! 📢

Antibody-drug conjugates, or ADCs, precisely deliver a cancer-fighting drug to tumor cells.

In this video, we explain how ADCs work, how they are used in cancer care, and why they reduce side effects vs. traditional chemo.

https://t.co/iVvuBFf1ew

[David Grew 🛠🏥 @DoctorGrew]

PRIMR helps sponsors stay competitive by forecasting patient and investigator engagement patterns in trials. 🏁📈

https://t.co/Y8MfSTYrQd

#cancer #clinicaltrials #clinicalresearch #patienteducation #bladdercancer

[David Grew 🛠🏥 @DoctorGrew]

I’ll be sharing our story of converting simple pen and paper sketches into @PRIMR_MED - a global cancer clinical trial recruitment engine at #ASTRO25 next week in San Francisco.

I owe a lot to brilliant @jackbutcher, clear thinker @naval and great leverist @EricJorgenson

[PRIMR @PRIMR_MED]

PRIMR will be at #ASTRO25!

Founder @DoctorGrew presents Sept 29 (5–6 PM): “Scaling the Explanation: Digital Tools as a Force Multiplier in Cancer Care.”

He will share his journey from pen-and-paper drawings to building a global cancer education resource.

[David Grew 🛠🏥 @DoctorGrew]

New blog about the INDICATE Trial with @eaonc ECOG-ACRIN Cancer Research Group.

Using PSMA scans to help personalize treatment for recurrent #prostatecancer.

[PRIMR @PRIMR_MED]

📢 New Blog!

PET scans personalize recurrent #prostatecancer care. Learn about the INDICATE trial and its impact.

In this blog, we explore how the trial compares treatments for patients with metastases inside vs. outside the pelvis. #blog @eaonc

https://t.co/96Gnv9C2ww

[David Grew 🛠🏥 @DoctorGrew]

@SprakerMDPhD @PRIMR_MED @drbeckta Thanks for the shout out @SprakerMDPhD !!

[David Grew 🛠🏥 @DoctorGrew]

Unlike oral medications, low-dose radiation therapy (LDRT) may reduce osteoarthritis pain and improve function without side effects

In this video, we explore how LDRT offers a non-invasive solution for treating osteoarthritis.

https://t.co/cBUBf21d93

[David Grew 🛠🏥 @DoctorGrew]

The informed consent process ensures you have all the info needed for a decision on trial participation.

In this video, we explore the importance of reading and understanding the informed consent form by highlighting its key elements.

https://t.co/AX9A472XRE

[David Grew 🛠🏥 @DoctorGrew]

Double-blind studies reduce bias in clinical research.

In this video, we explore how "blinding" participants and researchers ensures accurate, reliable results.

https://t.co/ABqMse9bC3

[David Grew 🛠🏥 @DoctorGrew]

Multidisciplinary care empowers prostate cancer patients.

In this video, we explore how collaboration between urologists, radiologists, pathologists, and other specialists can optimize treatment and improve outcomes.

https://t.co/EqH6AM0uX1